Cargando…

Tissue Plasminogen Activator as a Possible Indicator of Breast Cancer Relapse: A Preliminary, Prospective Study

SIMPLE SUMMARY: Breast cancer is the most common malignant neoplasm and the leading cause of cancer death in women worldwide. The heterogeneity of breast cancer is a significant challenge facing modern medicine, especially at the stage of diagnosis. In recent years, a substantial role of fibrinolyti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wrzeszcz, Katarzyna, Słomka, Artur, Zarychta, Elżbieta, Rhone, Piotr, Ruszkowska-Ciastek, Barbara
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9104124/ https://www.ncbi.nlm.nih.gov/pubmed/35566525 http://dx.doi.org/10.3390/jcm11092398

Ejemplares similares

Unraveling the Angiogenic Puzzle: Pre-Treatment sVEGFR1 and sVEGFR2 Levels as Promising Prognostic Indicators in Early-Stage Breast Cancer Patients
por: Zarychta, Elżbieta, et al.
Publicado: (2023)

High Post-Treatment Leptin Concentration as a Prognostic Biomarker of the High Risk of Luminal Breast Cancer Relapse: A Six-Year Comprehensive Study
por: Kwiatkowska, Katarzyna, et al.
Publicado: (2022)

Impact of Adjuvant Treatment on Heparanase Concentration in Invasive, Unilateral Breast Cancer Patients: Results of a Prospective Single-Centre Cohort Study
por: Ruszkowska-Ciastek, Barbara, et al.
Publicado: (2021)

Hypercoagulability State Combined with Post-Treatment Hypofibrinolysis in Invasive Breast Cancer: A Seven-Year Follow-Up Evaluating Disease-Free and Overall Survival
por: Wrzeszcz, Katarzyna, et al.
Publicado: (2023)

Stromal Cell-Derived Factor 1α (SDF-1α) in Invasive Breast Cancer: Associations with Vasculo-Angiogenic Factors and Prognostic Significance
por: Zarychta, Elżbieta, et al.
Publicado: (2021)

Divergent Impact of Breast Cancer Laterality on Clinicopathological, Angiogenic, and Hemostatic Profiles: A Potential Role of Tumor Localization in Future Outcomes
por: Barbara, Ruszkowska-Ciastek, et al.
Publicado: (2020)

Cooperation between Angiogenesis, Vasculogenesis, Chemotaxis, and Coagulation in Breast Cancer Metastases Development: Pathophysiological Point of View
por: Zarychta, Elżbieta, et al.
Publicado: (2022)

Comprehensive analysis of haemostatic profile depending on clinicopathological determinants in breast cancer patients
por: Rhone, Piotr, et al.
Publicado: (2018)

Complex Analysis of Endothelial Markers as Potential Prognostic Indicators in Luminal Invasive Breast Carcinoma Patients: Outcomes of a Six-Year Observational Study
por: Kwiatkowska, Katarzyna, et al.
Publicado: (2023)

Pre-Operative Combination of Normal BMI with Elevated YKL-40 and Leptin but Lower Adiponectin Level Is Linked to a Higher Risk of Breast Cancer Relapse: A Report of Four-Year Follow-Up Study
por: Bielawski, Kornel, et al.
Publicado: (2020)

Low Pre-Treatment Count of Circulating Endothelial Progenitors as a Prognostic Biomarker of the High Risk of Breast Cancer Recurrence
por: Rhone, Piotr, et al.
Publicado: (2019)

Significant Interactions between Adipokines and Vitamin D Combined with the Estimated Glomerular Filtration Rate: A Geriatric Case Study
por: Biercewicz, Monika, et al.
Publicado: (2023)

Gestational Diabetes Mellitus Worsens the Profile of Cardiometabolic Risk Markers and Decrease Indexes of Beta-Cell Function Independently of Insulin Resistance in Nondiabetic Women with a Parental History of Type 2 Diabetes
por: Sokup, Alina, et al.
Publicado: (2014)

Increased number of endothelial progenitor cells in the blood of patients with psoriasis vulgaris
por: Małkowska, Justyna, et al.
Publicado: (2021)

Insulin resistance as estimated by the homeostatic method at diagnosis of gestational diabetes: estimation of disease severity and therapeutic needs in a population-based study
por: Sokup, Alina, et al.
Publicado: (2013)

Relapsing polychondritis detected in PET/CT
por: Czepczyński, Rafał, et al.
Publicado: (2012)

Enzymatic vitreolysis with recombinant tissue plasminogen activator for vitreomacular traction
por: Raczyńska, Dorota, et al.
Publicado: (2015)

The possible role of hypoxia in the affected tissue of relapsed clubfoot
por: Novotny, Tomas, et al.
Publicado: (2022)

Zinc-Triggered Induction of Tissue Plasminogen Activator and Plasminogen in Endothelial Cells and Pericytes
por: Cho, Mun-Kyung, et al.
Publicado: (2013)

Intrapericardial recombinant tissue plasminogen activator in purulent pericarditis- case series
por: Dybowska, Małgorzata, et al.
Publicado: (2020)

Preliminary Experience with Air Transfer of Patients for Rescue Endovascular Therapy after Failure of Intravenous Tissue Plasminogen Activator
por: TSUJIMOTO, Masanori, et al.
Publicado: (2015)

Ligand binding modulates the structural dynamics and activity of urokinase-type plasminogen activator: A possible mechanism of plasminogen activation
por: Kromann-Hansen, Tobias, et al.
Publicado: (2018)

Respiratory chest movement measurement as a chair quality indicator – preliminary observations
por: Szczygieł, Elżbieta, et al.
Publicado: (2015)

Tissue Plasminogen Activator and Plasminogen Activator Inhibitor-1 Levels in Patients with Acute Paraquat Intoxication
por: Seok, Su-Jin, et al.
Publicado: (2011)

Structural basis of specific inhibition of tissue-type plasminogen activator by plasminogen activators inhibitor-1
por: Gong, Lihu, et al.
Publicado: (2016)

Role of tissue-type plasminogen activator and plasminogen activator inhibitor-1 in psychological stress and depression
por: Tsai, Shih-Jen
Publicado: (2017)

Plasma tissue plasminogen activator and plasminogen activator inhibitor-1 in hospitalized COVID-19 patients
por: Zuo, Yu, et al.
Publicado: (2021)

Role of Tissue Plasminogen Activator in Loculated Ascites
por: Alkhero, Mohammed, et al.
Publicado: (2021)

Relationship between tissue plasminogen activator, plasminogen activator inhibitor and CT image in chronic subdural hematoma.
por: Lim, D. J., et al.
Publicado: (1995)

Clinical Outcomes of Endovascular Thrombectomy in Tissue Plasminogen Activator versus Non-Tissue Plasminogen Activator Patients at Primary Stroke Care Centers
por: Imbarrato, Gregory, et al.
Publicado: (2018)

Glucocorticoid-modulated gene expression of tissue- and urinary-type plasminogen activator and plasminogen activator inhibitor 1 and 2
Publicado: (1988)

Tissue Plasminogen Activator and Plasminogen Activator Inhibitor 1 Contribute to Sonic Hedgehog-Induced In Vitro Cerebral Angiogenesis
por: Teng, Hua, et al.
Publicado: (2012)

Relationship between serum and tear levels of tissue plasminogen activator and plasminogen activator inhibitor-1 in diabetic retinopathy
por: Jasmiad, Nurbadriah binti, et al.
Publicado: (2022)

PB1991: NEW MONOCYTE HEMATOLOGICAL PARAMETERS AS AN IMPORTANT INDICATOR OF MDS PATIENTS WITH POSITIVE OGATA SCORE - A PRELIMINARY STUDY
por: Dudzik, Alicja, et al.
Publicado: (2023)

An Endothelial Storage Granule for Tissue-Type Plasminogen Activator
por: Emeis, J.J., et al.
Publicado: (1997)

Recombinant tissue plasminogen activator in the treatment of suprachoroidal hemorrhage
por: Kunjukunju, Nancy, et al.
Publicado: (2011)

Improvement of Psychotic Symptoms and the Role of Tissue Plasminogen Activator
por: Hoirisch-Clapauch, Silvia, et al.
Publicado: (2015)

Management of Pediatric Strokes With Alteplase (Tissue Plasminogen Activator)
por: Filatov, Asia, et al.
Publicado: (2021)

Roles of the tissue-type plasminogen activator in immune response
por: Seillier, Célia, et al.
Publicado: (2022)

Atlas-Based Segmentation in Extraction of Knee Joint Bone Structures from CT and MR
por: Zarychta, Piotr
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_f2j5uu7pm8a2lqmq6av7ge0qs9